Test Strips Market Report 2026

Test Strips Market Overview

• Test Strips market size has reached to $68.13 billion in 2025 • Expected to grow to $85.21 billion in 2030 at a compound annual growth rate (CAGR) of 4.5% • Growth Driver: Increasing Prevalence Of Diabetes Fueling The Growth Of The Market Due To Sedentary Lifestyles And Rising Blood Sugar Disorders • Market Trend: Advanced Drug Detection Test Strips Enhance Accuracy And User Experience • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Test Strips Market?

Test strips are small, disposable devices coated with chemical reagents that react with specific substances in a liquid sample, such as urine or blood. Their primary purpose is to provide quick, easy, and on-the-spot detection or measurement of various analytes, helping monitor health conditions or detect contaminants. The main product types of test strips are blood test strips, urine test strips and others. Blood test strips are small, thin strips designed to detect specific substances or chemicals in a drop of blood. These are distributed through various channels, including online retail, offline retail, direct sales, hospital supply chains, and specialized distributors. These test strips are applied in various areas, including diabetes, infectious disease, cardiac marker testing, pregnancy and fertility testing, and others, serving end users such as hospitals and clinics, homecare, diagnostic labs, and other end users.

What Is The Test Strips Market Growth Forecast?

The test strips market size is expected to see steady growth in the next few years. It will grow to $85.21 billion in 2030 at a compound annual growth rate (CAGR) of 4.5%. The growth in the forecast period can be attributed to technological advancements in biosensors, rising adoption of digital health platforms, expansion of hospital and homecare services, growing prevalence of chronic diseases, integration with AI-powered diagnostic tools. Major trends in the forecast period include rising adoption of home-based testing solutions, increasing demand for multi-parameter test strips, integration with mobile health applications, expansion of point-of-care diagnostic testing, growing focus on rapid and accurate detection.

Global Test Strips Market Segmentation

1) By Product Type: Blood Test Strips, Urine Test Strips, Other Product Types 2) By Distribution Channel: Online Retail, Offline Retail, Direct Sales, Hospital Supply Chains, Specialized Distributors 3) By Application: Diabetes, Infectious Disease, Cardiac Marker Testing, Pregnancy And Fertility Testing, Other Applications 4) By End User: Hospitals And Clinics, Homecare, Diagnostic Labs, Other End Users Subsegments: 1) By Blood Test Strips: Glucose Test Strips, Cholesterol Test Strips, Hemoglobin Test Strips, Ketone Test Strips, Coagulation Test Strips 2) By Urine Test Strips: pH Test Strips, Protein Test Strips, Glucose Test Strips, Ketone Test Strips, Leukocyte And Nitrite Test Strips, Specific Gravity Test Strips, Microalbumin Test Strips 3) By Other Product Types: Saliva Test Strips, Sweat Test Strips, Multi-Parameter Test Strips, Drug of Abuse Test Strips, Fertility Or Pregnancy Test Strips

What Is The Driver Of The Test Strips Market?

The increasing prevalence of diabetes is expected to propel the growth of the test strips market going forward. Diabetes is a chronic medical condition where the body is unable to regulate blood sugar or glucose levels properly. The increasing prevalence of diabetes is due to sedentary lifestyles, as lack of physical activity leads to weight gain and reduced insulin sensitivity, both of which heighten the risk of developing the disease. Test strips help monitor diabetes by providing quick and accurate blood glucose readings, making daily management easier and more effective. They offer a convenient and straightforward way to track blood sugar levels, supporting timely treatment decisions and improved health outcomes. For instance, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, marking an 18% increase from 3,065,825 cases in 2022. Therefore, the increasing prevalence of diabetes is driving the growth of the test strips industry.

Key Players In The Global Test Strips Market

Major companies operating in the test strips market are Johnson & Johnson, F Hoffmann La Roche Ltd, Abbott Laboratories, Abbott Diabetes Care, Siemens Healthcare GmbH, Becton Dickinson and Company, bioMerieux SA, Bio Rad Laboratories Inc, TaiDoc Technology Corporation, Macherey Nagel GmbH and Co KG, OneTouch, EKF Diagnostics Holdings plc, Bionime Corporation, ACON Laboratories Inc, i SENS Inc, BTNX Inc, ARKRAY Inc, Ascensia Diabetes Care, LifeScan Inc, Nova Biomedical, Trividia Health, Nipro Diagnostics

Global Test Strips Market Trends and Insights

Major companies operating in the test strip market are focusing on developing advanced products, such as drug detection test strips, to enhance detection capabilities, user experience, and accuracy. Drug detection test strips refer to small, portable devices designed to quickly identify the presence of specific drugs or their metabolites in biological samples such as urine or saliva. For instance, in September 2024, Greenlane Holdings Inc., a US-based cannabis accessories distributor company, launched fentaNYL, Xylazine, and drink spike detection test strips, which are advanced safety tools designed to detect the presence of harmful substances such as fentaNYL, Xylazine, and common drink-spiking agents such as benzodiazepines and ketamine. These strips offer high sensitivity and accuracy, providing reliable results within two minutes. They feature a simple, user-friendly design, typically a dip-and-read or drop-and-wait format with clear visual indicators for ease of interpretation, making them portable and disposable, ideal for use in bars, nightclubs, festivals, and personal safety kits.

What Are Latest Mergers And Acquisitions In The Test Strips Market?

In February 2025, Safe Supply Streaming Co. Ltd., a Canada-based medical company, acquired Safety Strips Tech Corp. for an undisclosed amount. With this acquisition, Safe Supply Streaming aims to expand its product portfolio in the diagnostic test strips market, enhance technological capabilities, and strengthen its presence in key global markets. Safety Strips Tech Corp. is a US-based company specializing in diagnostic test strips for medical use.

Regional Outlook

North America was the largest region in the test strips market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Test Strips Market?

The test strips market consists of sales of glucose test strips, pH test strips, ketone test strips, cholesterol test strips, and drug-of-abuse test strips. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.